SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-008571
Filing Date
2021-01-14
Accepted
2021-01-14 07:06:28
Documents
6
Period of Report
2021-01-14

Document Format Files

Seq Description Document Type Size
1 6-K d901629d6k.htm 6-K 8347
2 EX-99.1 d901629dex991.htm EX-99.1 63665
3 GRAPHIC g901629g0114035607160.jpg GRAPHIC 5274
4 GRAPHIC g901629g0114035607649.jpg GRAPHIC 1371
5 GRAPHIC g901629g0114035607846.jpg GRAPHIC 1651
6 GRAPHIC g901629g0114035608033.jpg GRAPHIC 2786
  Complete submission text file 0001193125-21-008571.txt   88952
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 21527490
SIC: 2834 Pharmaceutical Preparations